China Gender-affirming Hormone Therapy Study

Recruiting now

Conditions studied: Transgender, Gender Incongruence

In brief

Data about transgender medical care, especially the gender-affirming hormone therapy (GAHT) is extremely insufficient in China. Few evidence exists in the physical and psychological effects of the hormonal treatment in Chinese transgender population. CGAHT is designed to describe the social and mental condition of transgender people who are seeking for formal GAHT, and to investigate the physical and psychological effects of GAHT on this population in China.

Key facts

Study ID
NCT05318755
Run by
Peking University Third Hospital
People needed
240
Starts
2022-04-16
Expected to finish
2028-12-31
Last updated by the study team
2024-11-07

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.